Circular RNA circESYT2 serves as a microRNA‐665 sponge to promote the progression of hepatocellular carcinoma through ENO2

Author:

Du Wei1,Li Ying1,Wang Xufeng1,Xie Sunzhe1,Ci Hongfei1,Zhou Jiaming1,Zhu Ningqi1,Chen Zule1,Zheng Yan2,Jia Huliang13ORCID

Affiliation:

1. Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital Fudan University Shanghai China

2. Department of Pancreatic Surgery, Shanghai General Hospital, Shanghai Key Laboratory of Pancreatic Disease, Institute of Pancreatic Disease Shanghai Jiao Tong University School of Medicine Shanghai China

3. Cancer Metastasis Institute Fudan University Shanghai China

Abstract

AbstractCircular RNAs (circRNAs) have emerged as crucial regulators in tumor progression, yet their specific role in hepatocellular carcinoma (HCC) remains largely uncharacterized. In this study, we utilized high‐transcriptome sequencing to identify the upregulation of circESYT2 (hsa_circ_002142) in HCC tissues. Functional experiments carried out in vivo and in vitro revealed that circESYT2 played a significant role in maintaining the growth and metastatic behaviors of HCC. Through integrative analysis, we identified enolase 2 (ENO2) as a potential target regulated by circESYT2 through the competitive endogenous RNA sponge mechanism. Additional gain‐ or loss‐of‐function experiments indicated that overexpression of circESYT2 led to a tumor‐promoting effect, which could be reversed by transfection of microRNA‐665 (miR‐665) mimic or ENO2 knockdown in HCC cells. Furthermore, the direct interaction between miR‐665 and circESYT2 and between miR‐665 and ENO2 was confirmed using RNA immunoprecipitation, FISH, RNA pull‐down, and dual‐luciferase reporter assays, highlighting the involvement of the circESYT2/miR‐665/ENO2 axis in promoting HCC progression. These findings shed light on the molecular characteristics of circESYT2 in HCC tissues and suggest its potential as a biomarker or therapeutic target for HCC treatment.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3